Strategic partnerships Leverage Enlighten Mobility’s ongoing collaborations with Gravitrex and AngelEye Health to identify co-selling or integration opportunities in rehabilitation tech and NICU to neurological recovery workflows. Positions for mutual customers seeking end-to-end neuromotor care solutions.

Early detection focus Target hospitals and NICUs interested in automated non-invasive neuromotor screening like the GMat and the EDNA portfolio, noting a prior sale of EDNA assets to AngelEye Health which indicates demand and potential for similar NPC or license deals with neonatal and pediatric care networks.

Healthtech integration Pitch to health systems and care providers that run multiple platforms (Squarespace, WordPress, Shopify, Google Workspace) to streamline procurement, onboarding, and user training for neuromotor rehabilitation tech, highlighting potential for bundled solutions and managed services.

Clinical validation Emphasize research-backed pedigree and collaborations with academic centers (Nationwide Children’s Hospital, Nathalie Maitre) to pursue pilot programs, outcome studies, and reimbursement-ready deployments that appeal to risk-averse purchasers seeking proven impact.

Scale-ready revenue Position Enlighten Mobility as a versatile partner with a lean team capable of rapid deployment and support; target mid-market hospitals and regional health systems with 1k to 5k bed footprints that align with their $1M–$10M revenue profile and growth trajectory in neuromotor tech.